Skip to content
healthcare.dev

Abiraterone

NDC 68001-673, Abiraterone Acetate, tablet, from BluePoint Laboratories.

Product NDC
68001-673
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210686
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE500 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
68001-673-066800106730660 TABLET in 1 BOTTLE (68001-673-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/32f6b83d-c743-4934-9a20-1b5bf9f4eea3
  • NADAC price for package 68001067306

    GET /v1/drugs/nadac/68001067306

Use it

Look up 68001-673 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.